AngioDynamics, Inc. (UG2.F)

5.80 +0.15 (+2.65%) At close: 09:55PM CEST

AngioDynamics, Inc.

14 Plaza Drive
Latham, NY 12110
United States
518 795 1400
https://www.angiodynamics.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 815

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. James C. Clemmer	CEO, President & Director	923.49k	N/A	1964
Mr. Stephen A. Trowbridge	Executive VP & CFO	496.1k	74.46k	1974
Mr. Chad T. Campbell	Senior VP and GM of Global Vascular Access & Oncology Global Business Unit	391.33k	N/A	1971
Ms. Laura Piccinini	Senior VP & GM of International	417.45k	N/A	1969
Mr. Saleem M. Cheeks	Vice President of Communications	N/A	N/A	N/A
Mr. Benjamin H. Davis	Senior Vice President of Business Development	N/A	N/A	1964
Ms. Marna I. Bronfen-Moore	Senior Vice President of Human Resources	N/A	N/A	1967
Mr. Warren G. Nighan	Senior Vice President of Quality & Regulatory Affairs	584.5k	N/A	1969
Ms. Kim L. Seabury	Senior Vice President of Information Technology	N/A	N/A	1967
Mr. Juan Carlos Serna	Senior Vice President of Scientific & Clinical Affairs	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Corporate Governance

AngioDynamics, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 4. The pillar scores are Audit: 9; Board: 2; Shareholder Rights: 6; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.